Beware of cardiac toxicity with hydroxychloroquine used in COVID-19: cardiologist

Cardiologists have warned of the need to monitor for cardiac complications of hydroxychloroquine if it is used as a treatment for COVID-19 disease. As Australia starts clinical trials of the drug and the government approves off label use of hydroxychloroquine for COVID-19, clinicians in France say they found the arrhythmia risks of the drug to ...

Already a member?

Login to keep reading.

© 2021 the limbic